SEC Comment Letter 0000000000-25-003768 to HCW Biologics Inc. (HCWB)
HCW Biologics Inc.
Date: April 8, 2025 · CIK: 0001828673 · Accession: 0000000000-25-003768
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286409
Letter
Re: HCW Biologics Inc. Registration Statement on Form S-1 Filed April 7, 2025 File No. 333-286409 Dear Hing Wong:
April 8, 2025
Hing Wong Chief Executive Officer HCW Biologics Inc. 2929 N Commerce Parkway Miramar, FL 33025
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jim Groth
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 8, 2025 Hing Wong Chief Executive Officer HCW Biologics Inc. 2929 N Commerce Parkway Miramar, FL 33025 Re: HCW Biologics Inc. Registration Statement on Form S-1 Filed April 7, 2025 File No. 333-286409 Dear Hing Wong: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jim Groth </TEXT> </DOCUMENT>